Phase 1 Study of Zoledronic Acid in Sickle Cell Disease

Clinical trial NCT00639392 · WITHDRAWN

Trial details

NCT number: NCT00639392
Sponsor: Virginia Commonwealth University
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2007-06-01
Primary completion: 2008-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.